<PAGE> 1
--------------------------------
OMB APPROVAL
--------------------------------
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response.... 14.90
--------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. _________)*
ArthroCare Corporation
-----------------------------------------
(Name of Issuer)
Common Stock
-----------------------------------------
(Title of Class of Securities)
043136 10 0
-----------------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing of this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
SEC 1745 (2-95)
Page 1 of 5 Pages
<PAGE> 2
CUSIP No. 043136 10 0 13G Page 2 of 5 Pages
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Philip E. Eggers, ###-##-####
---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
---------------------------------------------------------------------
3 SEC USE ONLY
---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
---------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF 473,750 shares
SHARES --------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 0
EACH --------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON WITH 473,750 shares
--------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
473,750 shares
---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN
SHARES* [ ]
---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.4%
---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT
<PAGE> 3
CUSIP No. 043136 10 0 Page 3 of 5 Pages
ITEM 1.
(a) Name of Issuer: ArthroCare Corporation
(b) Address of Issuer's Principal Executive Offices:
595 North Pastoria Avenue
Sunnyvale, CA 94086
ITEM 2.
(a) Name of Person Filing: Philip E. Eggers
(b) Address of Principal Business Office or, if none, Residence:
5366 Reserve Drive
Dublin, OH 43017
(c) Citizenship: United States
(d) Title of Class of Securities: Common Stock
(e) CUSIP Number: 043136 10 0
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b),
CHECK WHETHER THE PERSON IS A:
(a) [ ] Broker or Dealer registered under Section 15 of the Act
(b) [ ] Bank as defined in section 3(a)(6) of the Act
(c) [ ] Insurance Company as defined in section 3(a)(19) of the Act
(d) [ ] Investment Company registered under section 8 of the
Investment Company Act
(e) [ ] Investment Adviser registered under section 203 of the
Investment Advisers Act of 1940
(f) [ ] Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act
of 1974 or Endowment Fund, see Sec. 240.13d-1(b)1(ii)(F)
(g) [ ] Parent Holding Company, in accordance with
Sec. 240.13d-1(b)(ii)(G) (Note: See Item 7)
(h) [ ] Group, in accordance with Sec. 240.13d-1(b)(1)(ii)(H)
<PAGE> 4
CUSIP No. 043136 10 0 Page 4 of 5 Pages
ITEM 4. OWNERSHIP
(a) Amount Beneficially Owned: 473,750 shares
(b) Percent of Class: 5.4%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 473,750
(ii) shared power to vote or to direct the vote: 0
(iii) sole power to dispose or direct the disposition
of: 473,750
(iv) shared power to dispose or direct the disposition
of: 0
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the
following [ ]
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Inapplicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Inapplicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Inapplicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Inapplicable.
<PAGE> 5
CUSIP No. 043136 10 0 Page 5 of 5 Pages
ITEM 10.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired in the ordinary
course of business and were not acquired for the purpose of and do not have the
effect of changing or influencing the control of the issuer of such securities
and were not acquired in connection with or as a participant in any transaction
having such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 14, 1997
--------------------------------
Date
/s/ PHILIP E. EGGERS
--------------------------------
Signature
Philip E. Eggers
--------------------------------
Name/Title
